Literature DB >> 26218928

Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses.

Le Jiang1, Justin H Hickman1, Shang-Jui Wang1, Wei Gu1,2.   

Abstract

The p53 tumor suppressor is a multifaceted polypeptide that impedes tumorigenesis by regulating a diverse array of cellular processes. Triggered by a wide variety of stress stimuli, p53 transcriptionally regulates genes involved in the canonical tumor suppression pathways of apoptosis, cell-cycle arrest, and senescence. We recently discovered a novel mechanism whereby p53 inhibits cystine uptake through repression of the SLC7A11 gene to mediate ferroptosis. Importantly, this p53-SLC7A11 axis is preserved in the p53(3KR) mutant, and contributes to its ability to suppress tumorigenesis in the absence of the classical tumor suppression mechanisms. Here, we report that wild type p53 can induce both apoptosis and ferroptosis upon reactive oxygen species (ROS)-induced stress. Furthermore, we demonstrate that p53's functional N-terminal domain is required for its capacity to regulate oxidative stress responses and ferroptosis. Notably, activated p53 dynamically modulates intracellular ROS, causing an initial reduction and a subsequent increase of ROS levels. Taken together, these data implicate ferroptosis as an additional component of the cell death program induced by wild type p53 in human cancer cells, and reveal a complex and dynamic role of p53 in oxidative stress responses.

Entities:  

Keywords:  ROS; SLC7A11; ferroptosis; p53; transcription

Mesh:

Substances:

Year:  2015        PMID: 26218928      PMCID: PMC4825584          DOI: 10.1080/15384101.2015.1068479

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.

Authors:  Colleen A Brady; Dadi Jiang; Stephano S Mello; Thomas M Johnson; Lesley A Jarvis; Margaret M Kozak; Daniela Kenzelmann Broz; Shashwati Basak; Eunice J Park; Margaret E McLaughlin; Anthony N Karnezis; Laura D Attardi
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

3.  Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

Authors:  Tongyuan Li; Ning Kon; Le Jiang; Minjia Tan; Thomas Ludwig; Yingming Zhao; Richard Baer; Wei Gu
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

4.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

5.  Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma.

Authors:  Weijie Guo; Yingjun Zhao; Zhenfeng Zhang; Ning Tan; Fangyu Zhao; Chao Ge; Linhui Liang; Deshui Jia; Taoyang Chen; Ming Yao; Jinjun Li; Xianghuo He
Journal:  Cancer Lett       Date:  2011-08-22       Impact factor: 8.679

6.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

Review 7.  The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-) : cystine supplier and beyond.

Authors:  Marcus Conrad; Hideyo Sato
Journal:  Amino Acids       Date:  2011-03-16       Impact factor: 3.520

8.  Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug.

Authors:  P W Gout; A R Buckley; C R Simms; N Bruchovsky
Journal:  Leukemia       Date:  2001-10       Impact factor: 11.528

9.  CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.

Authors:  Takatsugu Ishimoto; Osamu Nagano; Toshifumi Yae; Mayumi Tamada; Takeshi Motohara; Hiroko Oshima; Masanobu Oshima; Tatsuya Ikeda; Rika Asaba; Hideki Yagi; Takashi Masuko; Takatsune Shimizu; Tomoki Ishikawa; Kazuharu Kai; Eri Takahashi; Yu Imamura; Yoshifumi Baba; Mitsuyo Ohmura; Makoto Suematsu; Hideo Baba; Hideyuki Saya
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

10.  Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia.

Authors:  Wan Zhang; Dunyaporn Trachootham; Jinyun Liu; Gang Chen; Helene Pelicano; Celia Garcia-Prieto; Weiqin Lu; Jan A Burger; Carlo M Croce; William Plunkett; Michael J Keating; Peng Huang
Journal:  Nat Cell Biol       Date:  2012-02-19       Impact factor: 28.824

View more
  53 in total

1.  Inhibition of tumor suppressor p53 preserves glycation-serum induced pancreatic beta-cell demise.

Authors:  Y Li; T Zhang; Q Huang; Y Sun; X Chang; H Zhang; Y Zhu; X Han
Journal:  Endocrine       Date:  2016-05-09       Impact factor: 3.633

2.  Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.

Authors:  Zhihui Zhou; Yanlin Yin; Qun Chang; Guanqun Sun; Jiahui Lin; Yalei Dai
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

3.  Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression.

Authors:  Shang-Jui Wang; Dawei Li; Yang Ou; Le Jiang; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell Rep       Date:  2016-10-04       Impact factor: 9.423

Review 4.  Iron and cancer: recent insights.

Authors:  David H Manz; Nicole L Blanchette; Bibbin T Paul; Frank M Torti; Suzy V Torti
Journal:  Ann N Y Acad Sci       Date:  2016-02-18       Impact factor: 5.691

Review 5.  Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.

Authors:  Wen Li; Feifei Li; Xia Zhang; Hui-Kuan Lin; Chuan Xu
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

Review 6.  xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.

Authors:  Jinyun Liu; Xiaojun Xia; Peng Huang
Journal:  Mol Ther       Date:  2020-09-02       Impact factor: 11.454

Review 7.  Nucleolus-derived mediators in oncogenic stress response and activation of p53-dependent pathways.

Authors:  Dariusz Stępiński
Journal:  Histochem Cell Biol       Date:  2016-05-03       Impact factor: 4.304

Review 8.  System Xc-: a key regulatory target of ferroptosis in cancer.

Authors:  Man-Ru Liu; Wen-Tao Zhu; Dong-Sheng Pei
Journal:  Invest New Drugs       Date:  2021-01-27       Impact factor: 3.850

Review 9.  p53 and Tumor Suppression: It Takes a Network.

Authors:  Anthony M Boutelle; Laura D Attardi
Journal:  Trends Cell Biol       Date:  2021-01-28       Impact factor: 20.808

Review 10.  Programmed cell death, redox imbalance, and cancer therapeutics.

Authors:  Xiaofeng Dai; Danjun Wang; Jianying Zhang
Journal:  Apoptosis       Date:  2021-07-08       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.